Stabilizer

A drug-dev.com article by Dr. William Small and Arsalan Khan It wouldn’t come as a surprise to anyone that active...

Recombinant proteins are large and complex molecules, whose therapeutic activity highly depends on their structure. Formulation of biopharmaceuticals aims at...

Huperzine A (HupA) is a selective acetylcholinesterase inhibitor used to treat Alzheimer’s disease. The existing dosage of HupA lacks brain...

As you maybe aware, polysorbates present a host of challenges for stabilizing biopharmaceuticals due to their own stability issues. To...

The aim of this study was to investigate the effects of various stabilizers on the encapsulation efficiency and release of...

Epilepsy is a brain disorder that affects millions of people worldwide and is usually managed using currently available antiepileptic drugs,...

Background The use of amino acids as excipients is a promising approach to improve the physical stability and powder dispersibility...

Cilnidipine (CLD) is extensively used in the treatment of hypertension; however, it has extremely low solubility which limits its clinical...

  Amorphous formulation technologies to improve oral absorption of poorly soluble active pharmaceutical ingredients (APIs) have become increasingly prevalent. Currently,...

Background: This study compared the properties of propofol bolus for induction of general anesthesia between proprietary and 3 generic formulations,...